publication . Article . Other literature type . 2019

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

A. N. Boyko; M. V. Davydovskaya; Khachanova Nv; M. N. Zakharova; N. N. Spirin; Ekaterina Popova; V. M. Alifirova; Ya. V. Vlasov; S. A. Sivertseva; F. A. Khabirov; ...
Open Access Russian
  • Published: 01 Nov 2019 Journal: Nevrologiâ, Nejropsihiatriâ, Psihosomatika, volume 11, issue 3, pages 16-25 (issn: 2074-2711, eissn: 2310-1342, Copyright policy)
  • Publisher: IMA-PRESS LLC
<jats:p>The paper presents a detailed algorithm for the treatment and follow-up of patients with recurrent multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab.</jats:p>
Persistent Identifiers
free text keywords: ocrelizumab, multiple sclerosis, recurrent multiple sclerosis, primary progressive multiple sclerosis, monoclonal antibody, lcsh:Neurology. Diseases of the nervous system, lcsh:RC346-429, medicine.drug, medicine, business.industry, business, In patient, Oncology, medicine.medical_specialty, medicine.disease, Internal medicine
Any information missing or wrong?Report an Issue